Ventricular tachycardia laboratory findings

Ventricular tachycardia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ventricular Tachycardia from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography
Cardiac MRI
Other Diagnostic Tests
Treatment
Medical Therapy
Electrical Cardioversion
Ablation
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ventricular tachycardia laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ventricular tachycardia laboratory findings
CDC onVentricular tachycardia laboratory findings
Ventricular tachycardia laboratory findings in the news
Blogs on Ventricular tachycardia laboratory findings
to Hospitals Treating Ventricular tachycardia laboratory findings
Risk calculators and risk factors for Ventricular tachycardia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

• Ionized calcium levels along with magnesium and phosphate levels should be obtained.

• Hypocalcemia, hypokalemia, and hypomagnesemia make patients vulnerable to monomorphic VT or torsade de pointes.

• Cardiac troponin I and cardiac troponin T levels along with CK-MB and LDH can help access myocardial ischemia or infarction.

• Digoxin blood levels should be ordered.

• Sometimes recreational drugs can result in ventricular tachycardia so a toxicology screen should also be obtained.